How we validate
The moat isn't the plant.
It's the dossier.
Every phytogenic company has access to the same herbs. What separates a defensible product from a commodity blend is what you can prove about it. Here is how Truevet proves every claim — and why our evidence travels with the product.
Live from Truevet's product-validation system.
01 · Moat 01
Standardised phytomarkers
A quantified marker molecule on every Certificate of Analysis.
Anyone can grind a herb. The difference between a commodity blend and a defensible product is a marker molecule you can measure — and guarantee — in every batch. Each Truevet flagship carries at least one phytomarker with a minimum specification (for example, min. 30% AKBA in Salixivet), quantified by HPLC or GC-MS and released on the batch CoA. If a batch misses spec, it doesn't ship.
02 · Moat 02
Documented mechanism of action
One owned biological story per product — not folklore.
For every product we name the pathway: COX-2 and 5-LOX modulation for phytogenic analgesia, membrane disruption for antimicrobials, methanogen suppression for enteric-methane reduction. Where we can, we back it with a repeatable in-vitro assay. A mechanism you can point to is what turns a 'natural additive' into a category.
03 · Moat 03
Controlled, head-to-head trials
Tested against the drug or the incumbent — not a placebo.
The trials that matter are randomised, controlled and blinded, run against the actual standard of care: a broiler Eimeria challenge head-to-head with toltrazuril, not a sugar pill. We measure the endpoints a vet respects — oocyst counts, lesion scores, feed conversion, somatic cell count, validated pain scores — and we publish. A trial is what names the category and earns the claim.
04 · Moat 04
Country registrations
Legally cleared to be sold where it's used.
Evidence is only useful if the product can cross the border. We build the regulatory dossier market by market, so a distributor's registration path is real, not aspirational — and so the claim on the label is one a regulator has already seen.
Why it compounds
Each claim is traced to the trial that earned it.
Inside Truevet, every marketing claim links to the controlled trial that produced it, and every batch is checked against its marker spec before release. Nothing on a product page is a number someone typed — it is a result our validation system stands behind. When a buyer's regulatory team asks us to prove a figure, it is one reference away, not a scramble. That is what it means to treat the dossier as the moat.
Questions
How we validate, in brief.
What makes a Truevet product different from a generic essential-oil blend?
Standardisation and evidence. Every flagship carries a quantified phytomarker on its Certificate of Analysis, a documented mechanism of action, and — for our lead products — a controlled trial run head-to-head against the drug or incumbent. Commodity blends rarely have any of the four.
Are Truevet's claims backed by controlled trials?
The claims we publish are traced to a controlled, endpoint-driven trial in our validation system. We deliberately separate proven results from research targets, and only published, trial-backed claims appear on our product pages.
Can I see the full evidence dossier for a product?
Yes. Truevet partners receive the complete product dossier — phytomarker specs, mechanism, trial designs and results, and registration status — on request. Reach out through the partners page.
How does Truevet guarantee batch-to-batch consistency?
Each batch is assayed against the product's marker specification and released on a Certificate of Analysis. A batch that fails to meet spec is not released for sale.